These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15955178)

  • 1. Left ventricular lead performance in cardiac resynchronization therapy: impact of lead localization and complications.
    Albertsen AE; Nielsen JC; Pedersen AK; Hansen PS; Jensen HK; Mortensen PT
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):483-8. PubMed ID: 15955178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year performance of a preshaped lead for left ventricular stimulation.
    Schuchert A; Seidl K; Pfeiffer D; Oltmanns G; Dänschel W; Aydin MA; Paul V
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1610-4. PubMed ID: 15613123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
    Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC;
    J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization.
    Becker M; Hoffmann R; Schmitz F; Hundemer A; Kühl H; Schauerte P; Kelm M; Franke A
    Am J Cardiol; 2007 Dec; 100(11):1671-6. PubMed ID: 18036367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term performance of the attain model 4193 left ventricular lead.
    Johnson WB; Abraham WT; Young JB; Wheelan K; Smith AL; Chang Y; Brinkman P;
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1111-6. PubMed ID: 19719485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-site left ventricular cardiac resynchronization therapy.
    Padeletti L; Colella A; Michelucci A; Pieragnoli P; Ricciardi G; Porciani MC; Tronconi F; Hettrick DA; Valsecchi S
    Am J Cardiol; 2008 Dec; 102(12):1687-92. PubMed ID: 19064025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study.
    Klein N; Klein M; Weglage H; Przibille O; Fischer S; Trappe HJ; Birkenhauer F; Pfeiffer D;
    Europace; 2012 Jun; 14(6):826-32. PubMed ID: 22277645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and technical determinants of long-term performance of coronary sinus leads.
    La Rocca V; Bertaglia E; Solimene F; Accogli M; Iuliano A; Marrazzo N; De Luca De Masi G; Scaccia A; Donnici G; Chiariello P; Turco P; De Simone A; Ciardiello C; Stabile G
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):40-4. PubMed ID: 19770774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
    Van de Veire NR; Marsan NA; Schuijf JD; Bleeker GB; Wijffels MC; van Erven L; Holman ER; De Sutter J; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2008 Apr; 101(7):1023-9. PubMed ID: 18359325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety.
    Gras D; Böcker D; Lunati M; Wellens HJ; Calvert M; Freemantle N; Gervais R; Kappenberger L; Tavazzi L; Erdmann E; Cleland JG; Daubert JC;
    Europace; 2007 Jul; 9(7):516-22. PubMed ID: 17540662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for endocardial resynchronization therapy: initial experience with transapical implantation of the left ventricular lead.
    Kassai I; Mihalcz A; Foldesi C; Kardos A; Szili-Torok T
    Heart Surg Forum; 2009 Jun; 12(3):E137-40. PubMed ID: 19546062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of left ventricular lead location on outcomes in the COMPANION study.
    Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of cardiac resynchronization therapy in patients with congestive heart failure.
    Niu HX; Hua W; Wang FZ; Zhang S; Chen KP; Chen X
    Chin Med J (Engl); 2006 Mar; 119(6):449-53. PubMed ID: 16584641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial lead implantation techniques for biventricular pacing via left lateral mini-thoracotomy, video-assisted thoracoscopy, and robotic approach.
    Mair H; Jansens JL; Lattouf OM; Reichart B; Dabritz S
    Heart Surg Forum; 2003; 6(5):412-7. PubMed ID: 14721823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.